Drug Discovery & Pharmaceuticals

RSS

UT Southwestern research shows potential of new DNA vaccine in preventing Alzheimer’s disease

A new DNA vaccine when delivered to the skin prompts an immune response that produces antibodies to protect against toxic proteins associated with Alzheimer's disease – without triggering severe brain swelling that earlier antibody treatments caused in some patients.

23 May 2017

New research combines metals and organic acids as viable alternative to antibiotics

Antibiotics are an effective means of treating bacterial contamination. But extensive use of antibiotic substances in medicine and agriculture has resulted in increasingly antibiotic-resistant bacteria.

23 May 2017

Investigational biologic may reduce need for systemic corticosteroids in patients with severe asthma

An investigational biologic may reduce the need for adults with severe asthma to take an oral corticosteroid to control their asthma, according to a randomized controlled trial presented at the ATS 2017 International Conference.

22 May 2017

Supercomputer study of the brain could lead to safer and more effective anesthetics

Researchers have used a supercomputer to show how proteins in the brain control electrical signals, in a breakthrough that could lead to safer and more effective drugs and anesthetics.

22 May 2017

Complex malaria vaccine protects monkeys against virulent parasite strains

Researchers from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, modified an experimental malaria vaccine and showed that it completely protected four of eight monkeys that received it against challenge with the virulent Plasmodium falciparum malaria parasite.

22 May 2017

Scientists to develop drugs for treating cognitive deficits in Huntington's disease sufferers

Scientists at the University of Sussex have started work on a multi-million pound project to develop drugs to treat the debilitating loss of cognitive function associated with Huntington's disease.

19 May 2017

New findings could lead to first broadly effective ebolavirus therapies and vaccines

After analyzing the blood of a survivor of the 2013-16 Ebola outbreak, a team of scientists from academia, industry and the government has discovered the first natural human antibodies that can neutralize and protect animals against all three major disease-causing ebolaviruses.

19 May 2017

Seventh Wave announces collaboration with Yecuris to study new liver disease therapies

Seventh Wave Laboratories, a consulting-based contract research organization that assesses the safety and efficacy of pharmaceutical products and medical devices, has announced an exclusive collaboration with Yecuris Corporation, a global leader in the development and use of humanized models in drug development research.

18 May 2017

Research paves way for safer and more effective drugs to treat type 2 diabetes

Research led by the University of Adelaide is paving the way for safer and more effective drugs to treat type 2 diabetes, reducing side effects and the need for insulin injections.

18 May 2017

MR Solutions to showcase latest MRI imaging technology at World Preclinical Congress in Boston

MR Solutions, with offices in the UK and Boston, will be showing their latest state of the art 3T to 9.4T superconducting, cryogen-free MRI imaging technology with optional PET and SPECT imaging modalities on stand 407 at the 16th annual World Preclinical Congress in Boston on June 13th to 15th. The congress focusses on the very latest trends and technologies impacting the preclinical drug discovery and development world.

18 May 2017

Researchers develop new strategy that can revolutionize HIV vaccine design

Vaccines are an essential tool for preventing and treating serious infectious diseases such as polio, chicken pox and measles. But so far it has not been possible to develop vaccines capable of contributing to the treatment and prevention of chronic infectious diseases such as HIV and hepatitis C.

17 May 2017

Integrated BioBank of Luxembourg publishes "2016 In Review"

IBBL (Integrated BioBank of Luxembourg) is pleased to publish today its new digital annual report. “2016 In Review” looks back into the year 2016 in a refreshing way and highlights IBBL’s key achievements. Broadly speaking, it seems that IBBL has entered a transition phase in its history, having become a well established, valued and trusted partner in biomedical research.

17 May 2017

Prototype drug prevents lung cancer tumors in mice by using novel mechanism

Lung cancer tumors were prevented in mice by a novel small molecule that directly activates a tumor suppressor protein.

16 May 2017

New type of eye drop could potentially revolutionize treatment of AMD

Scientists at the University of Birmingham have developed a type of eye drop which could potentially revolutionize the treatment of one of the leading causes of blindness in the UK.

15 May 2017

New spherical nucleic acid drug crosses blood-brain barrier to target brain tumors in animals

The first drug using spherical nucleic acids to be systemically given to humans has been developed by Northwestern University scientists and approved by the Food and Drug Administration as an investigational new drug for an early-stage clinical trial in the deadly brain cancer glioblastoma multiforme.

12 May 2017

Drug Discovery & Pharmaceuticals

UT Southwestern research shows potential of new DNA vaccine in preventing Alzheimer’s disease

New research combines metals and organic acids as viable alternative to antibiotics

Investigational biologic may reduce need for systemic corticosteroids in patients with severe asthma

Supercomputer study of the brain could lead to safer and more effective anesthetics

Complex malaria vaccine protects monkeys against virulent parasite strains

Scientists to develop drugs for treating cognitive deficits in Huntington's disease sufferers

New findings could lead to first broadly effective ebolavirus therapies and vaccines

Seventh Wave announces collaboration with Yecuris to study new liver disease therapies

Research paves way for safer and more effective drugs to treat type 2 diabetes

MR Solutions to showcase latest MRI imaging technology at World Preclinical Congress in Boston

Researchers develop new strategy that can revolutionize HIV vaccine design

Integrated BioBank of Luxembourg publishes "2016 In Review"

Prototype drug prevents lung cancer tumors in mice by using novel mechanism

New type of eye drop could potentially revolutionize treatment of AMD

New spherical nucleic acid drug crosses blood-brain barrier to target brain tumors in animals

Developing a Micro-CT Scanner for Preclinical Imaging

The Importance of Flexibility in Spectrophotometry

Containing Airborne Contaminants

Milestones in the History of microCT

Productive Pipetting - Are Robots the Solution?

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News